Novartis
-
‘So fortunate’: Alberta baby ‘wins’ drug lottery for $2.8M spinal muscular atrophy treatmentHarper Hanki, who is just over a year old, was diagnosed with spinal muscular atrophy Type 1 (SMA 1) when she was just seven months old.HealthOct 25, 2020
-
Kaysen Martin’s family frustrated as they await decision on $2.8M drug coverageThe mother of two-year-old Kaysen Martin says it's unrealistic for her family to raise the $2.8 million needed for her son's drug coverage.HealthJul 24, 2020
-
Fighting for Reign: Alberta boy’s family says he needs $2.8M treatment for rare disorderReign Johnston's family met Kaysen Martin's when both babies were in Edmonton's Stollery Children's Hospital. The boys have the same rare disorder and their families say they both need the same expensive treatment.HealthJul 14, 2020
![]()
-
Alberta family raising $2.8 million for baby to receive cure for spinal muscular atrophy in U.S."It was deemed the world's most expensive therapy." An Alberta family is hoping their 10-month-old baby will be able to receive a cure for his disease in the U.S.HealthJan 30, 2020
![]()
-
FDA approves most expensive medicine ever, priced at $2M per treatmentThe medicine, sold by the Swiss drugmaker Novartis, is a gene therapy that treats an inherited condition called spinal muscular atrophy.ScienceMay 24, 2019
![]()
-
Mobile breast health bus rolls into MontrealA bilingual, mobile breast health exhibit is rolling into town to mark Breast Cancer Awareness Month.Sep 23, 2014
![]()
-
First-of-a-kind heart failure drug saves lives, cuts hospitalizations: studyA new study suggests a first-of-a-kind, experimental drug to treat heart failure may lower the chances of death or hospitalization by about 20 per cent.HealthSep 1, 2014
![]()
-
Google teams up with Novartis on contact lens glucose monitorGoogle has joined forces with Swiss pharmaceutical company Novartis to bring its contact lens glucose monitor to market.HealthJul 15, 2014
![]()
-
Novartis, GSK, Lilly sign multibillion-dollar dealsDrugmaker Novartis says it has signed several multibillion-dollar deals with GlaxoSmithKline and Lilly that will affect some 15,000 of its employees.MoneyApr 22, 2014
![]()
-
Novartis cuts 300 jobs as Mississauga plant to shut down in new yearNovartis AG is shutting down its Ciba Vision plant in Mississauga, Ont., in the new year, resulting in the loss of 300 jobs.Dec 13, 2013
![]()
